- March 8, 2021
10:00 AM - 2:30 PM ET
On March 8, 2021, FDA is hosting a virtual public meeting on Patient-Focused Drug Development for Vitiligo. FDA is interested in hearing patients’ perspectives on the impact of vitiligo on daily life and patient views on treatment approaches.
- Health effects and daily impacts of their vitiligo
- Treatment goals
- Decision factors considered when seeking out or selecting a treatment
This website will be updated as meeting materials are developed.
March 8, 2021
10:00 a.m. - 2:30 p.m. EST
Registration information will be available closer to the meeting date.